ReviewNew biotechnology2019

Antibody-cytokine fusion proteins: A novel class of biopharmaceuticals for the therapy of cancer and of chronic inflammation.

Patrizia Murer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.